Skip to content

Client Update: Where there’s smoke, there may be coverage: an insurer’s obligation to indemnify for medical cannabis

Jon O’Kane and Jamie Watson

Legal cannabis will have numerous implications for insurers. The federal Cannabis Act (discussed here), the provincial acts (discussed here) and the regulations (discussed here) are all going to add layers of nuance to the governance of cannabis in Canada.

Auto insurers will be affected by the uncertainty created by impaired driving, as we discuss in our article: Driving high – the future is hazy for Canadian automobile insurers once cannabis goes legal. However, other insurers, who deal with health and benefits, are already grappling with medical cannabis and coverage – as is discussed in the Nova Scotia Human Rights Tribunal decision of Skinner v Board of Trustees of the Canadian Elevator Industry Welfare Trust Fund, 2017 CanLII 3240 (NS HRC) (“Skinner“).

Skinner: what is it about?

Gordon “Wayne” Skinner worked for ThyssenKrupp Elevator Canada when he was injured on the job in a motor vehicle accident in 2010. After two other medications became ineffective in managing his symptoms, Mr. Skinner obtained a medical cannabis license in 2012. Once he exhausted his employer’s insurer’s coverage limit of $25,000, Mr. Skinner turned to the Canadian Elevator Industry Welfare Trust Plan (the “Trust”) to cover his medicinal cannabis. The Trust provides health and related benefits for employees and former employees working in the unionized sector of the Canadian elevator industry.

The Trust denied the request for coverage, taking the position that (a) medical cannabis had not been approved by Health Canada and, consequently, lacked a drug identification number (“DIN”); and, (b) Skinner’s injuries were the result of an otherwise compensable workplace accident and therefore ought to be covered by the provincial Medicare plan.

Mr. Skinner complained to the Nova Scotia Human Rights Commission (the “Commission”). Earlier this year, a Board of Inquiry (“BOI”) issued its decision. The BOI concluded that denial of coverage for medical cannabis amounted to unjustifiable discrimination and ordered the Trust to reimburse certain expenses.

Skinner provides guidance on how to draft language limiting coverage for medical cannabis within an insurance or group benefits policy. However, the impact of this decision may change, as an appeal is presently slated for October 2017 before the Nova Scotia Court of Appeal.

Skinner’s implications for insurers and coverage providers (at present)

1. Medical cannabis should be explicitly excluded from coverage, if that is the intent.

In Skinner, the BOI concluded it was not necessary that cannabis be assigned a DIN as a condition for coverage. Since the Trust’s plan in Skinner included coverage for both “drugs” and “medicines”, the BOI concluded it was prima facie discriminatory to deny coverage for medical cannabis as opposed to other medicines (thereby imposing a burden on the Trust to prove that the denial was justifiable).

2. Coverage for medical cannabis cannot be denied arbitrarily. Insurers or benefit providers seeking to deny coverage must be able to justify that decision with evidence.

In Skinner, there was little evidence presented that showed coverage of medicinal cannabis would have rendered the Trust financially unviable. The Trust argued it would cost $60 per day to provide the medicinal cannabis to Mr. Skinner when justifying the alleged discrimination and denial of coverage. The BOI concluded that absent any context or comparators, the $60 daily expense to the Trust was not prohibitive to providing coverage to Mr. Skinner. Furthermore, the BOI decided that exclusion of medical cannabis was contrary to the purpose of the Trust’s plan, which was to maximize the benefits for members without compromising the financial viability of the trust funds supporting the plan.

Skinner‘s future implications 

Two items will have direct impacts on Skinner‘s continuing utility as a precedent in this area:

1. Legalized recreational cannabis, which is fast approaching, will require insurers and benefit providers to think critically about the relationship and overlap between recreational and medicinal cannabis when drafting coverage provisions; and,

2. The results of the October, 2017 appeal before the Nova Scotia Court of Appeal, which we will be following closely.

SHARE

Archive

Search Archive


 
 

Copyright Cases 2019: Back to Basics and Plenty More

March 23, 2020

In volume 35 of the Canadian Intellectual Property Review, Halifax partner Daniela Bassan, QC, has published an article regarding notable cases in Canadian copyright law. Daniela’s piece reviews the key themes and trends from 2019,…

Read More

Reunited and it feels so good: pensions, benefits and New Brunswick’s Unclaimed Property Act

March 20, 2020

Christopher Marr, TEP and Lauren Henderson Each year in New Brunswick, millions of dollars sit in limbo: unpaid wages, forgotten security deposits, overpayments to debt collectors, and benefits from estates, pensions and employee benefit plans,…

Read More

COVID-19 – leading law forward using DocuSign

March 20, 2020

Amid the COVID-19 pandemic, our Firm is focusing on business continuity, including supporting the business continuity of our clients. Practice innovation investments we have made help our business to continue “as usual” even when the…

Read More

COVID-19 public health emergency in Newfoundland and Labrador – what you need to know

March 19, 2020

John Samms and Amanda Whitehead This article sets out to summarize the Newfoundland and Labrador Government’s announcements in respect of its latest response to the COVID-19 pandemic as of approximately 3:00 p.m. on March 19,…

Read More

The Federal economic response to COVID-19

March 19, 2020

Brent McCumber, P.Eng. On March 18, 2020, the Government of Canada announced a significant economic response plan to mitigate the economic impact of COVID-19 on Canadians and businesses.  While this $82 billion plan contains many…

Read More

$82 billion federal government aid package – high points for employers

March 18, 2020

The Federal Government just announced various COVID-19-related measures in its Canada’s Covid-19 Economic Response Plan: Support for Canadians and Businesses.  The full statement can be found here. The following may be of particular interest to…

Read More

Nova Scotia announces mandatory quarantine for public sector staff and students returning from outside Canada

March 13, 2020

Brian Johnston, QC and Jennifer Thompson In an effort to mitigate the spread of COVID-19 in Nova Scotia, Premier Stephen McNeil and Chief Medical Officer, Dr. Robert Strang have announced that all public sector employees…

Read More

Government of Canada announces changes to Employment Insurance and Work-Share Program as part of $1 billion COVID-19 fund

March 12, 2020

Jennifer Thompson As employees and employers grapple with the practical implications of a potential COVID-19 outbreak, the Government of Canada has stepped up to the plate with an announcement of a $1 billion fund to…

Read More

COVID-19: Keep calm and consider the issues!

March 6, 2020

Rick Dunlop, Jennifer Thompson, Alycia Novacefski, Kyle Hartlen, Scott Campbell and Rebecca Saturley The impact of COVID-19, commonly referred to as coronavirus, will vary by organization. Each organization, however, should consider various legal issues associated…

Read More

Nova Scotia releases new pension funding framework, effective April 1, 2020

February 28, 2020

Level Chan and Dante Manna On February 26, 2020, the Nova Scotia Government released its regulations establishing a new defined benefit pension funding framework for the province. The amendments to the Pension Benefits Regulations (“PBR”)…

Read More

Search Archive


Scroll To Top